Related Experiment Videos
5-Fluorouracil interferes with paclitaxel cytotoxicity against human solid tumor cells
K R Johnson1, L Wang, M C Miller
1Department of Pathology, Experimental Oncology, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Summary
5-fluorouracil (5-FU) significantly reduces paclitaxel
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Paclitaxel is an antimitotic agent effective against solid tumors.
- Paclitaxel induces apoptosis and mitotic arrest in cancer cells.
- The precise mechanism of paclitaxel-induced cell death remains unclear.
Purpose of the Study:
- To investigate if cell cycle arrest at different phases impacts paclitaxel-induced apoptosis.
- To explore the interaction between 5-fluorouracil (5-FU) and paclitaxel in solid tumor cells.
Main Methods:
- Utilized 5-fluorouracil (5-FU) to arrest tumor cells at the G1-S phase.
- Administered paclitaxel and 5-FU simultaneously to solid tumor cells.
- Assessed paclitaxel's cytotoxic effects on mitotic arrest and apoptosis.
Main Results:
- 5-FU significantly repressed paclitaxel's cell-killing activity in solid tumor cells.
- 5-FU inhibited both paclitaxel-induced mitotic arrest and apoptosis.
- 5-FU likely interferes with paclitaxel's action by preventing entry into the G2-M phase.
Conclusions:
- Combining paclitaxel and 5-FU may reduce therapeutic efficacy in solid tumors.
- 5-FU's pre-arrest effect diminishes paclitaxel's cytotoxic and apoptotic activities.
- Clinical combination chemotherapy with paclitaxel and 5-FU warrants re-evaluation for metastatic breast cancer.